Enter to open, tab to navigate, enter to select
Antitrust risk-shifting provisions in ResMed Corp./Brightree LLC merger agreement
| February 19, 2016 • Antitrust Risk-shifting • $800 million (subject to purchase price adjustment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.